CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $8,851,122 | +17.1% | 351,374 | +51.0% | 0.05% | +2.0% |
| Q4 2023 | $7,557,583 | -3.7% | 232,684 | -19.3% | 0.05% | -15.5% |
| Q3 2023 | $7,851,406 | +252.9% | 288,178 | +188.2% | 0.06% | +286.7% |
| Q2 2023 | $2,224,755 | -1.3% | 99,989 | -3.9% | 0.02% | +7.1% |
| Q1 2023 | $2,253,203 | -57.9% | 104,026 | -60.5% | 0.01% | -54.8% |
| Q4 2022 | $5,351,644 | +71.9% | 263,498 | +117.0% | 0.03% | +72.2% |
| Q3 2022 | $3,114,000 | -25.1% | 121,454 | -30.5% | 0.02% | -28.0% |
| Q2 2022 | $4,158,000 | -39.7% | 174,873 | -42.9% | 0.02% | -56.9% |
| Q1 2022 | $6,891,000 | +129.2% | 306,012 | +101.6% | 0.06% | +100.0% |
| Q4 2021 | $3,006,000 | +176.5% | 151,828 | +174.8% | 0.03% | +107.1% |
| Q3 2021 | $1,087,000 | +89.0% | 55,258 | +111.3% | 0.01% | +133.3% |
| Q2 2021 | $575,000 | +186.1% | 26,147 | +210.2% | 0.01% | +100.0% |
| Q1 2021 | $201,000 | -16.9% | 8,429 | -8.8% | 0.00% | 0.0% |
| Q4 2020 | $242,000 | -54.3% | 9,239 | -69.6% | 0.00% | -62.5% |
| Q3 2020 | $530,000 | -74.3% | 30,435 | -75.2% | 0.01% | -77.8% |
| Q2 2020 | $2,064,000 | +98.1% | 122,728 | +40.0% | 0.04% | +28.6% |
| Q1 2020 | $1,042,000 | -15.1% | 87,643 | -13.6% | 0.03% | +27.3% |
| Q4 2019 | $1,227,000 | -11.0% | 101,423 | +3.9% | 0.02% | -18.5% |
| Q3 2019 | $1,379,000 | +372.3% | 97,576 | +273.2% | 0.03% | +440.0% |
| Q2 2019 | $292,000 | -52.1% | 26,147 | -49.7% | 0.01% | -75.0% |
| Q1 2019 | $610,000 | +25.5% | 51,998 | +42.9% | 0.02% | -13.0% |
| Q4 2018 | $486,000 | +71.1% | 36,379 | +131.5% | 0.02% | +53.3% |
| Q4 2017 | $284,000 | -41.3% | 15,714 | -37.3% | 0.02% | -44.4% |
| Q3 2017 | $484,000 | +18.6% | 25,080 | -27.5% | 0.03% | +3.8% |
| Q2 2017 | $408,000 | -17.7% | 34,597 | -23.5% | 0.03% | -25.7% |
| Q1 2017 | $496,000 | -3.7% | 45,220 | -36.2% | 0.04% | -14.6% |
| Q4 2016 | $515,000 | +1220.5% | 70,883 | +587.5% | 0.04% | +1950.0% |
| Q3 2015 | $39,000 | – | 10,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,372,001 | $98,287,000 | 4.68% |
| TANAKA CAPITAL MANAGEMENT INC | 79,574 | $934,000 | 2.82% |
| Consonance Capital Management LP | 3,747,453 | $43,995,000 | 2.78% |
| S&T BANK/PA | 613,740 | $7,205,000 | 1.62% |
| AJ WEALTH STRATEGIES, LLC | 595,834 | $6,995,000 | 1.16% |
| Capital Impact Advisors, LLC | 193,694 | $2,522,000 | 1.12% |
| TEALWOOD ASSET MANAGEMENT INC | 154,615 | $1,815,000 | 0.77% |
| AMI ASSET MANAGEMENT CORP | 722,932 | $8,487,000 | 0.63% |
| Birchview Capital, LP | 50,000 | $587,000 | 0.37% |
| FEDERATED HERMES, INC. | 11,176,281 | $131,210,000 | 0.32% |